Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-008-7 | CAS number: 112-82-3
Endpoint summary
Administrative data
Description of key information
ACUTE TOXICITY: ORAL
The acute oral toxicity of 1-bromhexadecane was determined to be >2500 mg/kg according to the key study which was performed in line with OECD guideline 423.
ACUTE TOXICITY: DERMAL
The acute dermal toxicity of 1-bromohexadecane was determined to be > 2000 mg/kg according to the key study which was performed in line with OECD guideline 402 and EU Method B.3.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Value:
- mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Value:
- mg/kg bw
Additional information
Acute Toxicity: Oral
A robust GLP compliant study has been used to address acute oral toxicity. Brunt (2003a) was performed in accordance with OECD Guideline 423. The LD₅₀ of the test material was determined by exposing six female Sprague Dawley rats to a limit test of 2000 mg/kg. Under the conditions of the test no systemic signs of toxicity were reported over a period of 14 days and the LD₅₀ was determined to be >2500 mg/kg. The study was performed to standardised guidelines and performed to a good standard; the study was assigned a reliability score of 1 using the principles for assessing data quality as set out in Klimisch (1977).
Acute Toxicity: Dermal
A robust GLP compliant study has been used to address acute dermal toxicity. Brunt (2003b) was performed in accordance with OECD Guideline 402 and EU Method B.3. The LD₅₀ of the test material was determined by exposing ten Sprague Dawley rats to 2000 mg/kg in a limit test. Under the conditions of the test no systemic signs of toxicity were reported over a period of 14 days and the LD₅₀ was determined to be > 2000 mg/kg. The study was performed to standardised guidelines and performed to a good standard; the study was assigned a reliability score of 1 using the principles for assessing data quality as set out in Klimisch (1977).
Justification for classification or non-classification
Acute Toxicity: Oral
The acute oral toxicity study indicates that the test material has no effect which requires classification. Therefore the material does not require classification in line with Regulation 1272/2008.
Acute Toxicity: Dermal
The acute dermal toxicity study indicates that the test material has no effect which requires classification. Therefore the material does not require classification in line with Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
